SAFE SUGAR™
Very-low-glycemic crystalline sweetener platform presented for food manufacturing, institutional nutrition systems, and metabolic-health reformulation.
Explore SAFE SUGAR™Lathell Nutraceuticals LLC is focused on medical-grade nutrition, metabolic health technologies, ingredient innovation, physiological intelligence platforms, and related health system development.
Across the site, the company’s work is presented through ingredient systems, platform technologies, product development, monitoring concepts, and broader health-focused innovation categories. The homepage is designed to bring those areas together in a clearer, more complete way without changing the rest of the site.
Major areas shown throughout the website include very-low-glycemic ingredient systems, metabolic health technologies, physiological monitoring platforms, biosignal-focused concepts, and supporting pages for products, research, market context, and contact.
Medical-grade nutrition and product development presented across multiple categories and health-focused applications throughout the site.
Ingredient systems and related technologies connected to glycemic, metabolic, and food-system positioning.
Platform concepts spanning ingredient innovation, physiological intelligence, monitoring systems, and related health technology development.
Supporting pages connect products and platform concepts to research, technical context, use-case discussion, and broader application areas.
The website includes product pages covering a wide range of health-focused formulations and category-specific offerings.
In addition to products, the site presents broader systems and platform ideas connected to monitoring, biosignals, and advanced health technology structure.
The homepage is structured to move visitors directly into existing product pages, technology pages, research pages, and company pages already on the site.
The site presents an integrated portfolio focused on medical-grade nutrition, metabolic health innovation, next-generation ingredient systems, physiological intelligence, monitoring concepts, and related health technology development. This homepage brings those areas together in a more detailed public-facing format.
Very-low-glycemic crystalline sweetener platform presented for food manufacturing, institutional nutrition systems, and metabolic-health reformulation.
Explore SAFE SUGAR™Physiological intelligence platform presented around biosignal analysis, interpretation, and broader health-technology applications.
Explore OMNIPHYX™Overview page covering ingredient platforms, biosignal systems, monitoring concepts, and related technology directions shown across the site.
View Technology PlatformsPage focused on the broader market context surrounding next-generation ingredient systems and related platform categories.
View Market OpportunityPage for manufacturers, institutions, investors, and other groups reviewing partnership and licensing information.
Explore PartnershipsThe homepage can now function as a more complete entry point into the existing website. Visitors can move from here into products, research, platform pages, market pages, and company information without the homepage feeling thin or unfinished.
Direct entry into ingredient and product pages already built into the site.
Direct movement into technology platform pages and biosignal-related sections.
Connection to supporting research, technical, and science-oriented pages already within the website structure.
Clear movement into contact, partnership, institutional, and other company-facing pages.
This version gives the homepage more substance by explaining the company’s visible categories in a broader way. It stays descriptive, keeps the tone public-facing, and avoids internal commentary while giving visitors more to understand on the first page.
The website presents ingredient-oriented work connected to metabolic health, glycemic positioning, reformulation direction, and related food-system applications. SAFE SUGAR™ and related categories sit inside this broader area of focus.
The site also presents platform concepts connected to biosignal interpretation, monitoring logic, health system visibility, device-oriented structures, and broader physiological intelligence applications through OMNIPHYX™, BSS™, and related pages.
Beyond the lead platform pages, the website includes product pages, research pages, technical sections, and supporting materials that give broader context to the company’s work across categories.
The homepage also needs to support the company-facing side of the site by helping visitors reach market context pages, partnership pages, contact pages, and other existing sections without duplication or clutter.
Use the homepage to move into the company’s product pages, technology platform pages, research pages, market pages, and contact pages already built into the site.


SAFE SUGAR™ is Lathell’s very-low-glycemic sweetener platform designed for metabolic health, institutional nutrition, and food-system applications.
OMNIPHYX™ is Lathell’s physiological intelligence platform designed to support advanced system-level health technology applications.
BSS™ is the Bio-Signal Stability Scanner, a technology platform developed to support advanced physiological signal and device-based innovation.